Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice
1997

Comparative Study of Mitoxantrone Formulations in Mice

Sample size: 54 publication Evidence: moderate

Author Information

Author(s): KM Rentsch, DH Horber, RA Schwendener, H Wunderli-Allenspach, E Hanseler

Primary Institution: University Hospital Zurich

Hypothesis

How do different formulations of mitoxantrone affect its pharmacokinetics and cytotoxicity in mice?

Conclusion

The study found that while pH-MTO had a higher blood concentration, it did not improve cytotoxic effects compared to PA-MTO, which showed better tissue distribution and cytotoxicity.

Supporting Evidence

  • pH-MTO showed a tenfold increased AUC in blood compared with free MTO.
  • PA-MTO exhibited faster blood pharmacokinetics than free MTO.
  • Maximal tumor regression was achieved with PA-MTO, followed by pH-MTO and free MTO.

Takeaway

This study looked at different ways to deliver a cancer drug in mice and found that one method worked better at getting the drug to the tumor than another.

Methodology

Mice were injected with three formulations of mitoxantrone, and drug concentrations were measured in various organs using HPLC.

Limitations

The study was conducted only in mice, which may not fully represent human responses.

Participant Demographics

Female ICR mice and female athymic nude mice were used in the study.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication